In future studies, we will investigate the precise mechanism of the VCAM-1-D6 domain in VCAM-1-mediated cell invasion and evaluate the in vivo efficacy of VCAM-1-D6 huMab in lung cancer animal models. This evidence concerns the gene VCAM1 and lung carcinoma.